nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

12.06.2018 | Letter to the Editor

Medical, social, and economic consequences of type 2 diabetes therapy with medicinal products from the group of DPP-4i, SGLT-2i, and GLP-1 RA

verfasst von: Zornitsa Mitkova, Konstantin Mitov, Vasil Valov, Manoela Manova, Alexandra Savova, Maria Kamusheva, Dimitar Tcharaktchiev, Zhivko Angelov, Galia Angelova, Guenka Petrova

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Excerpt

Incretins (DPP-4i and GLP-1 RA) as well as SGLT-2i comprise a broad range of pharmacological groups for type 2 diabetes treatment with not well established and documented long-term therapeutic and economic effect. We aimed to analyze the changes in HbA1c level and related risk of diabetes incidents appearance, as well as to value the cost and results of incretins and SGLT-2i-based therapy in Bulgaria. …

Siratton I, Adler A, Neil H, Matthews D, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405–12.CrossRef

Gale, EAM. The United Kingdom Prospective Diabetes Study [UKPDS]. 2014 Oct 20; Diapedia 1104085197 rev. no. 20. Available from: https://doi.org/10.14496/dia.1104085197.20

Wang T, Wang F, Zhou J, Tang H, Giovenale S. Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials. Diabetes Metab Res Rev. 2016;32(8):843–57. https://doi.org/10.1002/dmrr.2804.CrossRefPubMed

Halimi S, Vergès B. Adverse effects and safety of SGLT-2 inhibitors. Diabetes Metab. 2014;40(6 Suppl 1):S28–34. https://doi.org/10.1016/S1262-3636(14)72693-X.CrossRefPubMed

Titel: Medical, social, and economic consequences of type 2 diabetes therapy with medicinal products from the group of DPP-4i, SGLT-2i, and GLP-1 RA
verfasst von: Zornitsa Mitkova
Konstantin Mitov
Vasil Valov
Manoela Manova
Alexandra Savova
Maria Kamusheva
Dimitar Tcharaktchiev
Zhivko Angelov
Galia Angelova
Guenka Petrova
Publikationsdatum: 12.06.2018
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 4/2018
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-018-0657-7

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Association of HSD11B1 rs12086634 and HSD11B1 rs846910 gene polymorphisms with polycystic ovary syndrome in South Indian women

Statins protect diabetic myocardial microvascular endothelial cells from injury

Management of diabetes mellitus: need for empowering primary health care

Correction to: Diabetes Mellitus Knowledge Test: development, psychometric evaluation, and establishing norms for Indian population

Replication of MACF1 gene variant rs2296172 with type 2 diabetes susceptibility in the Bania population group of Punjab, India

Screening for diabetic retinopathy by non-mydriatic fundus camera in a Turkish population